Registry of patients with acute cardiovascular disease in a cardiac intensive care unit

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data from patients admitted to the Cardiac Intensive Care Unit (CICU) with acute cardiovascular diseases such as cardiogenic shock and acute myocardial infarction. The aim is to investigate clinical characteristics, outcomes, and factors predicting in-hospital mortality, while comparing results with established risk scores. Participants will be monitored during their hospitalization and for one year post-discharge, with data collected from medical records after obtaining informed consent. No additional treatments or visits are required beyond standard care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients admitted to the Cardiac Intensive Care Unit (CICU) through the Emergency Department of the UHI
* All patients transferred to the CICU from other hospital departments or other regional secondary hospitals
* Patients with an acute cardiovascular disease that requires treatment in a CICU
* Patients who are under scientific supervision of the 2nd Department of Cardiology
* Patients (or their relative/legal representatives) that have signed the informed consent form

Exclusion Criteria: None

Where it's running

• University Hospital of Ioannina
  Ioannina, Epirus, Greece Recruiting

Study contacts

• Study coordinator: Katerina K Naka, MD, PhD
• Email: anaka@uoi.gr
• Phone: +30 26510 99111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel

  This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07643610

• Comparing revascularization strategies for heart attack patients with cardiogenic shock

  This study is testing whether treating multiple blocked heart arteries right away helps heart attack patients in shock feel better compared to just fixing the main blockage.

  Recruiting Phase 4 Samsung Medical Center · Seoul · NCT05527717

• Collaborative effort to improve care for patients with cardiogenic shock

  This study is trying to gather information on how to better care for patients with cardiogenic shock caused by heart problems to help improve their treatment and outcomes.

  Recruiting at 3 sites University of Utah · Weston, Florida and 2 other locations · NCT05185492

• Using VA-ECMO to treat cardiogenic shock in heart attack patients

  This study is testing if using a special heart support machine along with another device can help heart attack patients in severe shock feel better compared to just standard treatment.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT04184635

• Education tailored to your health literacy to help follow heart-care instructions after a heart attack or heart failure

  This trial tests whether an educational toolkit adapted for people with limited health literacy helps patients hospitalized for a heart attack or worsening heart failure follow medical recommendations and avoid readmission.

  Recruiting at 4 sites Hospices Civils de Lyon · Bron and 3 other locations · NCT03951467

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.